Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00049998
Status:
COMPLETED
Last Update Posted:
2013-03-04
First Post:
2002-11-18
Brief Title:
Oral Topotecan Versus Intravenous Docetaxel In Pretreated Advanced Non-Small Cell Lung Cancer
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Organization Data
Organization:
GlaxoSmithKline
Class:
INDUSTRY
Study ID:
104864-A387
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
GlaxoSmithKline
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Study Director
Old Organization:
GSK